Oberhavel Kliniken GmbH
- Address
- Marwitzer Strasse 91, 16761 Hennigsdorf, Germany
Oberhavel Kliniken GmbH - Cardiovascular and Mental Health Research
Oberhavel Kliniken GmbH is a clinical research facility engaged in advancing therapeutic interventions across cardiovascular and psychiatric medicine. The center participates in pivotal multinational studies examining novel pharmacological approaches for conditions that significantly impact patient quality of life and long-term health outcomes.
- Major Depressive Disorder with anhedonia and relapse prevention strategies
- Lipid management and hypercholesterolemia treatment optimization
- Adjunctive therapy approaches combining innovative agents with standard-of-care medications
The facility's research portfolio demonstrates expertise in cardiovascular risk modification through advanced LDL-cholesterol lowering therapies, as well as psychiatric research focused on treatment-resistant depression and anhedonia. By participating in placebo-controlled, double-blind studies with rigorous relapse prevention endpoints and patient-centered outcome measures, Oberhavel Kliniken contributes valuable data to the development of next-generation treatments that address both the biological and quality-of-life dimensions of chronic disease management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Novartis Pharma AG1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Oberhavel Kliniken GmbH
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Adjunctive Aticaprant and Antidepressant Therapy for Relapse Prevention in Major Depressive Disorder with Moderate-to-Severe Anhedonia: A Randomized, Double-Blind Study | Janssen Cilag International | Phase III | Not Recruiting | Dec 2024 | Feb 2025 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Inclisiran | 2 | Unknown | 2022-04-08 | 2026-03-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.